EUVIMEDEUVIMED entdecken
Crossref

Morbidity and Mortality Pattern of Snakebite in Children and Anti-Snake Venom Dose Titration: A Descriptive Study from a Tertiary Care Hospital in South India

S. Suganya, Ganesh Shankar K., Nidhiyazhagan B.

International Journal of Current Pharmaceutical Review and Research · 30.04.2026 · 18 (04)

DOI: 10.25258/ijcpr.18.4.173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.04.2026. Verfasst von S. Suganya und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Snakebite is a neglected tropical disease causing significant morbidity and mortality in South Asian children. Data on anti-snake venom (ASV) dose titration in paediatric populations from South India remain limited. Objective of this study is to describe the epidemiological profile, clinical manifestations, complications, ASV dose requirements, and outcomes of snakebite envenomation in children admitted to a tertiary care PICU.

Methods

A descriptive study of 100 consecutive paediatric snakebite admissions receiving ASV was conducted in the PICU of Government Medical College Krishnagiri, Tamil Nadu. Data on demographics, bite characteristics, clinical features, complications, ASV dosing, and outcomes were recorded on a structured proforma and analysed using descriptive statistics.

Results

The majority of victims (86%) were in the 6–12 year age group; 56% were male. Rural residence (72%) and lower socioeconomic status (56%) predominated. Viper was the most frequent offending species (56%), followed by non-poisonous snakes (30%), cobra (10%), and krait (4%). The lower limb was most commonly bitten (57%), and 87% of bites occurred at night. Cellulitis was the most prevalent complication (60%), followed by haemotoxicity (56%), acute kidney injury (19%), and neurotoxicity (10%). ASV dose was titrated beyond WHO-recommended maximum (25 vials) in select cases with progressive cellulitis or renal failure, reaching up to 45 vials. The overall case-fatality rate was 5%.

Conclusion

Snakebite disproportionately affects rural school-age children in South India, with viper envenomation predominating. Clinically guided ASV dose titration beyond conventional limits improved outcomes in severe cases. Community awareness and timely medical intervention remain critical to reducing snakebite-associated mortality

Zitieren

APA

Suganya, S., K., G. S., & B., N. (2026). Morbidity and Mortality Pattern of Snakebite in Children and Anti-Snake Venom Dose Titration: A Descriptive Study from a Tertiary Care Hospital in South India. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.173

Vancouver

Suganya S, K. GS, B. N. Morbidity and Mortality Pattern of Snakebite in Children and Anti-Snake Venom Dose Titration: A Descriptive Study from a Tertiary Care Hospital in South India. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.173

BibTeX
@article{Suganya2026,
  author = {Suganya, S. and K., Ganesh Shankar and B., Nidhiyazhagan},
  title = {Morbidity and Mortality Pattern of Snakebite in Children and Anti-Snake Venom Dose Titration: A Descriptive Study from a Tertiary Care Hospital in South India},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {04},
  doi = {10.25258/ijcpr.18.4.173}
}
Kostenlos starten →